Rhone Ma Holdings Bhd (KLSE:5278) — Market Cap & Net Worth
Market Cap & Net Worth: Rhone Ma Holdings Bhd (5278)
Rhone Ma Holdings Bhd (KLSE:5278) has a market capitalization of $37.23 Million (RM148.27 Million) as of September 17, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #23095 globally and #542 in its home market, demonstrating a -1.47% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rhone Ma Holdings Bhd's stock price RM0.67 by its total outstanding shares 221297664 (221.30 Million). Also see 5278 asset base for a full breakdown of the balance sheet.
Rhone Ma Holdings Bhd Market Cap History: 2016 to 2026
Rhone Ma Holdings Bhd's market capitalization history from 2016 to 2026. Data shows growth from $38.51 Million to $37.23 Million (0.93% CAGR). Also see Rhone Ma Holdings Bhd (5278) cash conversion ratio for how efficiently the company converts equity into cash flow.
Rhone Ma Holdings Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rhone Ma Holdings Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Rhone Ma Holdings Bhd (5278) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.17x
Rhone Ma Holdings Bhd's market cap is 0.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.71x
Rhone Ma Holdings Bhd's market cap is 2.71 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $38.51 Million | $119.20 Million | $9.17 Million | 0.32x | 4.20x |
| 2017 | $39.19 Million | $137.49 Million | $13.91 Million | 0.29x | 2.82x |
| 2018 | $35.83 Million | $135.24 Million | $10.07 Million | 0.26x | 3.56x |
| 2019 | $32.66 Million | $119.06 Million | $8.64 Million | 0.27x | 3.78x |
| 2020 | $40.15 Million | $146.68 Million | $7.28 Million | 0.27x | 5.51x |
| 2021 | $37.47 Million | $169.43 Million | $11.27 Million | 0.22x | 3.33x |
| 2022 | $35.95 Million | $198.15 Million | $12.74 Million | 0.18x | 2.82x |
| 2023 | $36.98 Million | $202.93 Million | $12.08 Million | 0.18x | 3.06x |
| 2024 | $37.50 Million | $211.41 Million | $12.31 Million | 0.18x | 3.05x |
| 2025 | $38.34 Million | $223.68 Million | $14.16 Million | 0.17x | 2.71x |
Competitor Companies of 5278 by Market Capitalization
Companies near Rhone Ma Holdings Bhd in the global market cap rankings as of September 17, 2026. Review tangible net worth ratio of Rhone Ma Holdings Bhd to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Rhone Ma Holdings Bhd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Rhone Ma Holdings Bhd Historical Marketcap From 2016 to 2026
Between 2016 and today, Rhone Ma Holdings Bhd's market cap moved from $38.51 Million to $ 37.23 Million, with a yearly change of 0.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM37.23 Million | -2.90% |
| 2025 | RM38.34 Million | +2.22% |
| 2024 | RM37.50 Million | +1.41% |
| 2023 | RM36.98 Million | +2.86% |
| 2022 | RM35.95 Million | -4.05% |
| 2021 | RM37.47 Million | -6.68% |
| 2020 | RM40.15 Million | +22.95% |
| 2019 | RM32.66 Million | -8.84% |
| 2018 | RM35.83 Million | -8.59% |
| 2017 | RM39.19 Million | +1.76% |
| 2016 | RM38.51 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Rhone Ma Holdings Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $37.23 Million USD |
| MoneyControl | $37.23 Million USD |
| MarketWatch | $37.23 Million USD |
| marketcap.company | $37.23 Million USD |
| Reuters | $37.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Rhone Ma Holdings Bhd
Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company operates through Animal Health Products and Food Equipment; Food Ingredients; and others segments. It offers diagnostic laboratory analysis and consultation services to veterinary, agriculture, and … Read more